80_FR_12532 80 FR 12487 - National Center for Advancing Translational Sciences; Notice of Closed Meetings

80 FR 12487 - National Center for Advancing Translational Sciences; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 45 (March 9, 2015)

Page Range12487-12487
FR Document2015-05304

Federal Register, Volume 80 Issue 45 (Monday, March 9, 2015)
[Federal Register Volume 80, Number 45 (Monday, March 9, 2015)]
[Notices]
[Page 12487]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05304]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel Small Business Innovation Research 
(SBIR).
    Date: March 31, 2015.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm 1078, Bethesda, MD 
20892, 301-894-7319, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel CTSA Meeting 1.
    Date: April 8-9, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Carol Lambert, Ph.D., Acting Deputy Director, 
Office of Grants Management & Scientific Review, National Center for 
Advancing Translational Sciences (NCATS) National Institutes of 
Health, 6701 Democracy Boulevard, Democracy 1, Room 1076, Bethesda, 
MD 20892, 301-435-0814, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel 2015 CTSA Application Review.
    Date: April 15-16, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Guo He Zhang, Ph.D., MPH, Scientific Review 
Office, Office of Grants Management & Scientific Review, National 
Center for Advancing Translational Sciences (NCATS) National 
Institutes of Health, 6701 Democracy Boulevard, Democracy 1, Room 
1064, Bethesda, MD 20892, 301-435-0812, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B-Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS).

    Dated: March 3, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-05304 Filed 3-6-15; 8:45 am]
 BILLING CODE 4140-01-P



                                                                                        Federal Register / Vol. 80, No. 45 / Monday, March 9, 2015 / Notices                                                       12487

                                                                                                         TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1
                                                                                                                                                         Number of                             Average
                                                                                                                                      Number of                          Total annual
                                                                       21 CFR section 589.2001(f)                                                      responses per                         burden per       Total hours
                                                                                                                                     respondents                          responses
                                                                                                                                                         respondent                          respondent

                                                  One-time (initial) burden ......................................................                 1                 1                  1              80               80
                                                  Burden from future review ...................................................                    1                 1                  1              26               26
                                                     1 There   are no capital costs or operating costs associated with the collection of information.


                                                    Description of Respondents for                                   DEPARTMENT OF HEALTH AND                              Emphasis Panel 2015 CTSA Application
                                                  Reporting: The final regulation on BSE                             HUMAN SERVICES                                        Review.
                                                                                                                                                                             Date: April 15–16, 2015.
                                                  (73 FR 22720) included a provision that
                                                                                                                     National Institutes of Health                           Time: 8:00 a.m. to 5:00 p.m.
                                                  exempts cattle materials prohibited in                                                                                     Agenda: To review and evaluate grant
                                                  animal feed (CMPAF) from designated                                                                                      applications.
                                                                                                                     National Center for Advancing
                                                  countries from the prohibition on its use                                                                                  Place: Hilton Washington/Rockville 1750
                                                                                                                     Translational Sciences; Notice of                     Rockville Pike, Rockville, MD 20852.
                                                  in animal feed. A foreign country
                                                                                                                     Closed Meetings                                         Contact Person: Guo He Zhang, Ph.D.,
                                                  seeking this designation will submit a
                                                                                                                                                                           MPH, Scientific Review Office, Office of
                                                  written request to FDA that includes a                               Pursuant to section 10(d) of the                    Grants Management & Scientific Review,
                                                  variety of information about the                                   Federal Advisory Committee Act, as                    National Center for Advancing Translational
                                                  country’s BSE status (§ 589.2001(f)).                              amended (5 U.S.C. App.), notice is                    Sciences (NCATS) National Institutes of
                                                  During the past 6 years, FDA received                              hereby given of the following meetings.               Health, 6701 Democracy Boulevard,
                                                  2 requests from countries to be                                      The meetings will be closed to the                  Democracy 1, Room 1064, Bethesda, MD
                                                                                                                     public in accordance with the                         20892, 301–435–0812, zhanggu@
                                                  exempted from CMPAF restrictions.
                                                                                                                                                                           mail.nih.gov.
                                                                                                                     provisions set forth in sections
                                                  One-Time (Initial) Reporting Burden                                552b(c)(4) and 552b(c)(6), title 5 U.S.C.,            (Catalogue of Federal Domestic Assistance
                                                                                                                                                                           Program Nos. 93.859, Pharmacology,
                                                    There is a one-time burden to                                    as amended. The grant applications and                Physiology, and Biological Chemistry
                                                  countries that apply to FDA seeking to                             the discussions could disclose                        Research; 93.350, B–Cooperative Agreements;
                                                  be designated as not subject to                                    confidential trade secrets or commercial              93.859, Biomedical Research and Research
                                                                                                                     property such as patentable material,                 Training, National Institutes of Health, HHS).
                                                  restrictions applicable to CMPAF. We
                                                                                                                     and personal information concerning                     Dated: March 3, 2015.
                                                  estimate that each country that applies
                                                                                                                     individuals associated with the grant                 David Clary,
                                                  for an exclusion will spend 80 hours                               applications, the disclosure of which
                                                  putting information together to submit                                                                                   Program Analyst, Office of Federal Advisory
                                                                                                                     would constitute a clearly unwarranted                Committee Policy.
                                                  to FDA. Table 2 row 1 presents the one-                            invasion of personal privacy.
                                                  time burden for the exclusion. (See final                                                                                [FR Doc. 2015–05304 Filed 3–6–15; 8:45 am]
                                                                                                                       Name of Committee: National Center for
                                                  BSE regulation at 73 FR 22754).                                                                                          BILLING CODE 4140–01–P
                                                                                                                     Advancing Translational Sciences Special
                                                  Recurring Burden                                                   Emphasis Panel Small Business Innovation
                                                                                                                     Research (SBIR).                                      DEPARTMENT OF HEALTH AND
                                                    Countries that successfully petition                               Date: March 31, 2015.
                                                                                                                                                                           HUMAN SERVICES
                                                  FDA to be designated as exempt from                                  Time: 8:00 a.m. to 4:00 p.m.
                                                                                                                       Agenda: To review and evaluate grant
                                                  certain BSE-related restrictions                                                                                         National Institutes of Health
                                                                                                                     applications.
                                                  applicable to animal feed will be subject                            Place: Bethesda Marriott Suites, 6711
                                                  to future review by FDA to ensure that                                                                                   Submission for OMB Review; 30-Day
                                                                                                                     Democracy Boulevard, Bethesda, MD 20817.
                                                  their designation remains appropriate.                               Contact Person: Rahat Khan, Ph.D.,
                                                                                                                                                                           Comment Request Surveys and
                                                  As part of this process, FDA may ask                               Scientific Review Officer, Office of Scientific       Interviews To Support an Evaluation of
                                                                                                                     Review, National Center for Advancing                 the Innovative Molecular Analysis
                                                  designated countries from time-to-time
                                                                                                                     Translational Sciences, 6701 Democracy                Technologies (IMAT) Program (NCI)
                                                  to confirm that their BSE situation and
                                                                                                                     Blvd., Rm 1078, Bethesda, MD 20892, 301–
                                                  the information submitted by them in                                                                                     SUMMARY:   Under the provisions of
                                                                                                                     894–7319, khanr2@csr.nih.gov.
                                                  support of their original application                                                                                    section 3507(a)(1)(D) of the Paperwork
                                                                                                                       Name of Committee: National Center for
                                                  remains unchanged. We assume it will                                                                                     Reduction Act of 1995, the National
                                                                                                                     Advancing Translational Sciences Special
                                                  take FDA and the designated country                                Emphasis Panel CTSA Meeting 1.                        Institutes of Health (NIH), has submitted
                                                  undergoing a review in the future about                              Date: April 8–9, 2015.                              to the Office of Management and Budget
                                                  one third the time and effort it did when                            Time: 8:00 a.m. to 5:00 p.m.                        (OMB) a request for review and
                                                  the information was submitted. Table 2                               Agenda: To review and evaluate grant                approval of the information collection
                                                  row 2 presents the expected recurring                              applications.                                         listed below. This proposed information
                                                                                                                       Place: Hilton Washington/Rockville 1750             collection was previously published in
                                                  burden.                                                            Rockville Pike, Rockville, MD 20852.                  the Federal Register on December 4,
                                                    Dated: March 2, 2015.                                              Contact Person: Carol Lambert, Ph.D.,               2014, Vol. 79, Page 72004 and allowed
                                                                                                                     Acting Deputy Director, Office of Grants
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  Leslie Kux,                                                                                                              60-days for public comment. No public
                                                                                                                     Management & Scientific Review, National
                                                  Associate Commissioner for Policy.                                 Center for Advancing Translational Sciences
                                                                                                                                                                           comments were received. The purpose
                                                  [FR Doc. 2015–05356 Filed 3–6–15; 8:45 am]                         (NCATS) National Institutes of Health, 6701           of this notice is to allow an additional
                                                  BILLING CODE 4164–01–P                                             Democracy Boulevard, Democracy 1, Room                30 days for public comment. The
                                                                                                                     1076, Bethesda, MD 20892, 301–435–0814,               National Cancer Institute (NCI),
                                                                                                                     lambert@mail.nih.gov.                                 National Institutes of Health, may not
                                                                                                                       Name of Committee: National Center for              conduct or sponsor, and the respondent
                                                                                                                     Advancing Translational Sciences Special              is not required to respond to, an


                                             VerDate Sep<11>2014      18:04 Mar 06, 2015      Jkt 235001     PO 00000      Frm 00066   Fmt 4703   Sfmt 4703   E:\FR\FM\09MRN1.SGM   09MRN1



Document Created: 2015-12-18 12:05:56
Document Modified: 2015-12-18 12:05:56
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 31, 2015.
FR Citation80 FR 12487 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR